文献速递重症综合管理与镇静镇痛儿科与产科急症

西非埃博拉病毒病患者的重症监护支持与临床结局

Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa.
PubMed 文献 · Intensive Care Med · 2018-07-30
一句话结论在资源有限地区为埃博拉病毒病患者提供重症监护支持可行,并与生存改善和住院时间缩短相关。

本研究为回顾性队列研究,分析非政府组织EMERGENCY在塞拉利昂两个埃博拉治疗中心连续救治的229例埃博拉病毒病患者(Lakka 123例,Goderich 106例)。Lakka提供补液、对症、抗生素、抗疟治疗及医院级医疗护理;Goderich在此基础上增加器官支持,是非洲唯一配备人员和设备的ICU的埃博拉治疗中心(ETC-ICU)。主要终点为ETC内死亡率:粗分析显示Lakka 57.7% vs Goderich 50.0%,差异无统计学意义(p=0.19);校正后Goderich ICU-ETC死亡率较低(p=0.055),在病毒载量对数7.5–8.5 copies/ml的患者中以80%置信度观察到该差异。28天内无住院天数Goderich更多(7.7 vs 5.5天,p=0.03)。

要点

  • 229例埃博拉病毒病患者中,粗死亡率Lakka 57.7% vs Goderich 50.0%,差异无统计学意义(p=0.19)。
  • 校正潜在混杂因素(包括病毒载量以10为底的对数,copies/ml)后,Goderich ICU-ETC死亡率较低(p=0.055)。
  • 病毒载量对数在7.5–8.5 copies/ml的患者中,以80%置信度观察到ICU-ETC死亡率较低。
  • 28天内无住院天数Goderich ICU-ETC更多(7.7 vs 5.5天,p=0.03)。
  • 年龄和病毒载量对数与死亡率相关。

适用人群与场景

  • 塞拉利昂两个埃博拉治疗中心连续救治的229例埃博拉病毒病患者(Lakka 123例,Goderich 106例)。
  • 场景为资源有限地区的埃博拉治疗中心,Goderich设有配备人员和设备的ICU(ETC-ICU)。

处置流程与药物剂量

  • Lakka提供补液、对症治疗、抗生素、抗疟治疗及医院级医疗护理。
  • Goderich在Lakka治疗基础上增加器官支持。

研究设计与关键结果

  • 研究类型为回顾性队列研究,样本量229例(Lakka 123例,Goderich 106例),人群为埃博拉病毒病患者。
  • 干预为不同水平支持治疗:Lakka(补液、对症、抗生素、抗疟及医院级医疗护理)vs Goderich(在此基础上增加器官支持)。
  • 主要终点ETC内死亡率:粗分析Lakka 57.7% vs Goderich 50.0%,差异无统计学意义(p=0.19)。
  • 校正潜在混杂因素(包括病毒载量以10为底的对数,copies/ml,建模为分段线性函数)后,Goderich ICU-ETC死亡率较低(p=0.055)。
  • 病毒载量对数在7.5–8.5 copies/ml的患者中,以80%置信度观察到Goderich ICU-ETC死亡率较低。
  • 28天内无住院天数Goderich更多(7.7 vs 5.5天,p=0.03)。
  • 年龄和病毒载量对数与死亡率相关。

证据类型、等级与局限

  • 证据类型为回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在资源有限地区为埃博拉病毒病患者提供重症监护是可行的,并与生存改善和住院时间缩短相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: We investigate the impact on outcome of different levels of supportive treatment in Ebola virus disease (EVD). The NGO EMERGENCY delivered care sequentially at two Ebola Treatment Centres (ETC) in Sierra Leone: first at Lakka (fluids, symptomatic, antibiotic, antimalaria treatment, and hospital level medical care), and thereafter in Goderich, adding organ support in the only African ETC with an equipped and staffed intensive care unit (ETC-ICU).

METHODS: The primary outcome in this retrospective cohort study was in-ETC mortality. Secondarily, we used multivariable logistic regression to investigate the independent impact of the IC on mortality by comparing patients in two ETCs, adjusting for potential confounders, including the viral load (base-10 logarithm in copies/ml) (LVL), modelled as a piecewise linear function. Mortality was plotted versus LVL. Confidence bands were constructed by a bootstrap technique. The number of hospital-free days within 28 was computed to assess the burden of EVD.

RESULTS: Data from 229 EVD patients were analysed (123 in Lakka, 106 in Goderich). Crude analysis showed a non-statistically significant difference in mortality (57.7% in Lakka vs 50.0% in Goderich; p = 0.19). Age and LVL were associated with mortality. Adjusted mortality was lower at the Goderich ICU-ETC (p = 0.055). This difference was observed with 80% confidence for patients with LVL between 7.5 and 8.5 copies/ml. Hospital-free days (of 28 days) were greater (7.7 vs 5.5; p = 0.03) for patients treated in the ICU-ETC.

CONCLUSIONS: Provision of critical care to patients with EVD is feasible in resource-limited settings and was associated with improved survival and less time in hospital.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Langer M, Portella G, Finazzi S, et al. Intensive care support and clinical outcomes of patients with Ebola virus disease (EVD) in West Africa. Intensive Care Med. 2018. PMID: 30062576. doi:10.1007/s00134-018-5308-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。